FindTrial
Sign In

Confirmatory study of TRK-820 Soft Capsules

Confirmatory study of TRK-820 Soft Capsules-Intractable Pruritus in Patients with Chronic Liver Disease-

Status
Unknown
Phases
Phase 3
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCT2080221261
Enrollment
Unknown
Registered
2010-10-04
Start date
2010-10-04
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intractable Pruritus in Patients With Chronic Liver Disease

Interventions

investigational material(s) Generic name etc : TRK-820 INN of investigational material : Nalfurafine hydrochloride Therapeutic category code : 119 Other agents affecting central nervous system Dosage

Sponsors

Toray Industries,Inc.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Chronic Liver Disease It can be confirmed that the treatment of pruritus with antihistamines or antiallergics has not been adequately effective in such patients.

Exclusion criteria

Exclusion criteria: Malignant tumors except for early-stage hepatocellular carcinoma Allergy to opioid drugs

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026